leisure time -WSS

leisure time

author：leisure time 2025-09-29 01:29:21 - browse：49948

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Stanford president to resign after investigation of research

hotspot

WSS

Why the Crimean Bridge is key to Russia's war in Ukraine

FDA needs staff influx to meet gene therapy needs, Marks says

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

The woman behind the Dana Farber

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

hotspot

leisure time

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

'Reaching a detente': STAT's Helen Branswell on covering Covid

Alkermes shareholders re

Pfizer plans to depart BIO

Medicare details structure of new drug price negotiation program

Norman Reedus' Daryl Dixon

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In diabetes hearing, Sanders takes on a new foe: food makers

Dobbs anniversary: the lost opportunity of abortion as health care

States increasingly look to regulate hospital facility fees

explore

Celebrate National Dole Whip Day for 3 days this week at Disney

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

AI models in health care face new federal disclosure requirements

Seattle police shoot person suspected in downtown stabbing

Celebrate National Dole Whip Day for 3 days this week at Disney

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Wikipedia

hotspot

hotspot

entertainment